2-(2,4-difluorophenoxy)-2-methylpropanoic acid, 90.0%, 500mg

4-Chlorostyrene (stabilised with TBC), 99.00%, 100g

3-Amino-2,4-dichloro-5-fluoro-benzoic acid, 100mg

METHYL 3-(2-(HYDROXYMETHYL)-1H-INDOL-1-YL)PROPANOATE, 95.0%, 1g

4-Dimethylaminomethyl-benzoic acid, 95.0%, 10g

Methylhydroxyethyl cellulose, 3800-5300 mPas, powder, 250 g, plastic packaging.

Benzamide, 4,4'-[1,4-piperazinediylbis(methylene)]bis[N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, 97%, 50mg

(R)-4-benzyl-3-(5,5,5-trifluoropentanoyl)oxazolidin-2-one, 98%, 1g

2-({[(tert-Butoxy)carbonyl]amino}methyl)pyridine-4-carboxylic acid, 98%, 50mg

3-Ethynylaniline hydrochloride, 95.0%, 10g

2-Amino-6-tert-butyl-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carboxylic acid methyl ester, 98.0%, 5g

3,5-dibromo-1-(methoxymethyl)-1H-1,2,4-triazole, 5g

Ethyl 3-(3-(tert-Butylthio)-5-methoxy-1H-indol-2-yl)-2,2-dimethylpropanoate, 98%, 100mg